Riskpilot← Back to searchSign inGet full accessKulman Terapiat Oy
OYActiveY-tunnus 2796994-6Mannilantie 6Other human health activities · NACE 8690Est. 2016— employeeswww.kulmanterapiat.fi
Revenue 2022
EUR 17K
-69% vs 2021
EBITDA margin
-103.9%
-173% vs 2021
Equity ratio
-289.3%
Financial strength
Net profit 2022
EUR -22K
-205% vs 2021
| Revenue | EUR 17K | -69% |
| EBITDA | EUR -18K | -173% |
| Net profit | EUR -22K | -205% |
| Total assets | EUR 10K | -70% |
| Equity | EUR -29K | -323% |
| Employees | — | — |
Legal name
Kulman Terapiat Oy
Y-tunnus number
2796994-6
Legal form
Osakeyhtiö
NACE code
8690 · Other human health activities
Founded
24. marraskuuta 2016
Share capital
EUR 2 500
Employees
—
VAT registered
No
Audit selected
No
Last report
2022-11-30
Financial year
January – December
Signatory rights
Hallituksen jäsenet ja toimitusjohtaja kukin yksin
Company purpose
Kokonaisvaltaisten terveysalan palvelujen tuottaminen eri terapiamuotojen puolella, esim. jalkaterapia, fysioterapia, lymfaterapia, hieronta, akupunktio, osteopatia, myös laitos-, yritys- ja kotikäynnit. Hyvinvointia edistävien tuotteiden ja laitteiden myynti ja maahantuonti. Hyvinvointialan luentojen ja konsultointien antaminen ja järjestäminen. Kaikki laillinen liiketoiminta. Fysioterapia, Muu terveyspalvelu.
Address
Mannilantie 6
Website
www.kulmanterapiat.fi
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 |
|---|---|---|---|
| Revenue | 65 | 55 | 17 |
| Staff expenses | — | −0 | −0 |
| EBITDA | 23 | 24 | −18 |
| Depreciation & amort. | −1 | −1 | −2 |
| EBIT | 22 | 23 | −20 |
| Net financials | −3 | −2 | −2 |
| Profit before tax | 19 | 21 | −22 |
| Tax | −0 | −0 | −0 |
| Net profit | 19 | 21 | −22 |
| Item | 2020 | 2021 | 2022 |
|---|---|---|---|
| Total assets | 19 | 33 | 10 |
| Equity | −28 | −7 | −29 |
| Long-term debt | — | — | — |
| Short-term debt | 47 | 39 | 39 |
| Total debt | 47 | 39 | 39 |
EBITDA margin
-103.9%
This company
15.8%
Market median
-758% vs market
20202022
Equity ratio
-289.3%
This company
38.2%
Market median
-857% vs market
20202022
Return on equity
-2185600.0%
This company
18.4%
Market median
-11878361% vs market
20202022
Net profit margin
-128.1%
This company
8.1%
Market median
-1681% vs market
20202022
Asset turnover
1.72×
This company
1.12×
Market median
+54% vs market
20202022
Debt / equity
1.35×
This company
0.62×
Market median
-118% vs market
20202022
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
KK Chief Executive Officer | Chief Executive Officer | 2016 – 2023 |
JE Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2016 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
| Chairperson | 2016 – 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Kulman Terapiat Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Katja Kirsi Anneli Pennanen | Chief Executive Officer | 0 companies |
| Johanna Elina Salmela | Deputy Chief Executive Officer | 0 companies |
| Minttu Jores | Chairperson | 0 companies |